Journal
CHINESE JOURNAL OF INTEGRATIVE MEDICINE
Volume 20, Issue 1, Pages 3-10Publisher
SPRINGER
DOI: 10.1007/s11655-013-1551-2
Keywords
Chinese medicine; clinical oncology; anticancer agents; Fu-zheng therapy; angiogenesis inhibitor
Categories
Ask authors/readers for more resources
Chinese Medicine (CM) has been used for several thousand years, playing an important role in the prevention and treatment of diseases including cancer. In the recent four decades, a number of CM herbs have aroused extreme interest in the world-isolating anticancer components from medicinal herbs, using them as biological response modifiers, and most recently as angiogenesis inhibitors. The present review reports both the experimental and clinical results obtained in the field of clinical oncology, especially conducted by our group. The review also presents the possible future of integration of CM and modern medicine in basic research and clinical practice, especially when CM used as adjuvant and maintenance therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available